Doaa Hashad

513 total citations
33 papers, 393 citations indexed

About

Doaa Hashad is a scholar working on Molecular Biology, Epidemiology and Rheumatology. According to data from OpenAlex, Doaa Hashad has authored 33 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Rheumatology. Recurrent topics in Doaa Hashad's work include Sperm and Testicular Function (3 papers), Hepatitis B Virus Studies (3 papers) and Cancer-related molecular mechanisms research (3 papers). Doaa Hashad is often cited by papers focused on Sperm and Testicular Function (3 papers), Hepatitis B Virus Studies (3 papers) and Cancer-related molecular mechanisms research (3 papers). Doaa Hashad collaborates with scholars based in Egypt, Fiji and India. Doaa Hashad's co-authors include Iman M. Talaat, Abeer Ghazal, Neamat Hegazy, Nermeen El-Beltagy, Peter Scambler, Raffaella Cascella, Efstratios Vakirlis, Ariane Chapgier, Valerio Caputo and Rasha N.M. Saleh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science and Pollution Research and BioMed Research International.

In The Last Decade

Doaa Hashad

31 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doaa Hashad Egypt 12 185 157 58 44 39 33 393
Cheung Wong United States 10 185 1.0× 125 0.8× 74 1.3× 61 1.4× 37 0.9× 18 385
Jiangdong Xiang China 10 138 0.7× 115 0.7× 107 1.8× 60 1.4× 47 1.2× 25 371
Melanie von Brandenstein Germany 11 253 1.4× 187 1.2× 38 0.7× 62 1.4× 99 2.5× 45 484
Rui-Peng Jia China 15 316 1.7× 248 1.6× 27 0.5× 28 0.6× 85 2.2× 29 504
Ge Yu China 10 275 1.5× 144 0.9× 103 1.8× 20 0.5× 55 1.4× 20 428
Ryuji Nakano Japan 10 131 0.7× 155 1.0× 139 2.4× 17 0.4× 48 1.2× 26 363
Jia Wu China 8 203 1.1× 125 0.8× 43 0.7× 41 0.9× 16 0.4× 17 435
Hayriye Tatlı Doğan Türkiye 11 101 0.5× 88 0.6× 107 1.8× 19 0.4× 81 2.1× 41 338
Dariusz Samulak Poland 15 326 1.8× 140 0.9× 139 2.4× 54 1.2× 32 0.8× 51 485
Tomoko Kurita Japan 12 117 0.6× 44 0.3× 94 1.6× 106 2.4× 35 0.9× 50 359

Countries citing papers authored by Doaa Hashad

Since Specialization
Citations

This map shows the geographic impact of Doaa Hashad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doaa Hashad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doaa Hashad more than expected).

Fields of papers citing papers by Doaa Hashad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doaa Hashad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doaa Hashad. The network helps show where Doaa Hashad may publish in the future.

Co-authorship network of co-authors of Doaa Hashad

This figure shows the co-authorship network connecting the top 25 collaborators of Doaa Hashad. A scholar is included among the top collaborators of Doaa Hashad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doaa Hashad. Doaa Hashad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashad, Doaa, et al.. (2024). Targeted Sequencing of HER2-Positive Breast Cancer Mutations Revealed a Potential Association between PIK3CA and Trastuzumab Resistance. Asian Pacific Journal of Cancer Prevention. 25(11). 4051–4059. 1 indexed citations
3.
Hashad, Doaa, et al.. (2023). Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy. Human Genomics. 17(1). 43–43. 10 indexed citations
4.
Hashad, Doaa, et al.. (2019). The role of s100b as a predictor of the functional outcome in geriatric patients with acute cerebrovascular stroke. SHILAP Revista de lepidopterología. 55(1). 5 indexed citations
5.
Saleh, Rasha N.M., et al.. (2018). HIRA directly targets the enhancers of selected cardiac transcription factors during in vitro differentiation of mouse embryonic stem cells. Molecular Biology Reports. 45(5). 1001–1011. 5 indexed citations
6.
7.
Hashad, Doaa, et al.. (2017). The potential DNA toxic changes among workers exposed to antimony trioxide. Environmental Science and Pollution Research. 24(13). 12455–12461. 21 indexed citations
8.
Hashad, Doaa, et al.. (2017). Does detection of DDX4 mRNA in cell free seminal plasma represents a reliable non-invasive germ cell marker in patients with non-obstructive azoospermia?. European Urology Supplements. 16(3). e1001–e1002. 1 indexed citations
9.
Hashad, Doaa, et al.. (2015). Serum Chemerin Level: Does It Have a Role in Progression of Diabetic Nephropathy. 4(2). 13. 2 indexed citations
10.
Hashad, Doaa, et al.. (2015). Mitochondrial DNA Copy Number in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma. Genetic Testing and Molecular Biomarkers. 19(11). 604–609. 13 indexed citations
11.
Hashad, Doaa, et al.. (2014). Occurrence of the polyomavirus among kidney transplant recipients: A single-center study. Saudi Journal of Kidney Diseases and Transplantation. 25(2). 285–285. 3 indexed citations
12.
Rizk, Mohamed M., et al.. (2013). NEUTROPHIL GELATINASE – ASSOCIATED LIPOCALIN (NGAL) AS a BIOMARKER FOR ACUTE KIDNEY INJURY, MORBIDITY AND MORTALITY AFTER PEDIATRIC CARDIAC SURGERY. 1 indexed citations
13.
Hashad, Doaa, et al.. (2013). Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?. Archives of Gynecology and Obstetrics. 288(1). 167–172. 36 indexed citations
14.
Hashad, Doaa, et al.. (2012). Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer. Journal of Clinical Laboratory Analysis. 26(6). 467–472. 50 indexed citations
15.
Hashad, Doaa, et al.. (2011). Use of Free Fetal DNA in Prenatal Noninvasive Detection of Fetal RhD Status and Fetal Gender by Molecular Analysis of Maternal Plasma. Genetic Testing and Molecular Biomarkers. 15(9). 627–631. 12 indexed citations
16.
Hashad, Doaa, et al.. (2011). G2019S Mutation of the Leucine-Rich Repeat Kinase 2 Gene in a Cohort of Egyptian Patients with Parkinson's Disease. Genetic Testing and Molecular Biomarkers. 15(12). 861–866. 14 indexed citations
17.
Hashad, Doaa, et al.. (2011). Role of Glutathione-S-Transferase P1 Hypermethylation in Molecular Detection of Prostate Cancer. Genetic Testing and Molecular Biomarkers. 15(10). 667–670. 8 indexed citations
18.
Hashad, Doaa, et al.. (2011). Luteinising hormone β-subunit gene Gly102Ser variant and oxidative stress biomarkers in Egyptian infertile males. Andrologia. 44. 484–489. 7 indexed citations
19.
Hashad, Doaa, et al.. (2011). Toll like receptor 3 expression as a novel predictor of response to treatment in chronic hepatitis C virus patients. Scandinavian Journal of Clinical and Laboratory Investigation. 71(8). 641–646. 1 indexed citations
20.
Hashad, Doaa, et al.. (2010). MEFV Gene Mutations in Egyptian Patients with Familial Mediterranean Fever. Genetic Testing and Molecular Biomarkers. 14(2). 263–268. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026